Untitled

Shi, Chanjuan; Woltering, Eugene A.; Beyer, David T.; Klimstra, David S.; Mallin, Katherine; Bergsland, Emily K.; Amin, Mahul B.; Edge, Stephen B.; Greene, Frederick L.; Byrd, David R.; Brookland, Robert K.; Washington, Mary Kay; Gershenwald, Jeffrey E.; Compton, Carolyn C.; Hess, Kenneth R.; Sullivan, Daniel C.; Jessup, J. Milburn; Brierley, James D.; Gaspar, Lauri E.; Schilsky, Richard L.; Balch, Charles M.; Winchester, David P.; Asare, Elliot A.; Madera, Martin; Gress, Donna M.; Meyer, Laura

doi:10.1007/978-3-319-40618-3_33

Cited by 5 publications

(4 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…T3 and T4 are identical to the T-staging for colorectal adenocarcinoma, with a T3 lesion involving the pericolorectal tissues, and a T4 lesion penetrating the visceral peritoneum. 21 Rectal NETs have a favorable prognosis, with a 5-year survival of 88%. 14 Colonic NETs have the worst 5-year overall survival rate of all GI NETs at 62%.…”

Section: Hindgutmentioning

confidence: 99%

Small Bowel and Colorectal Carcinoids

Byrne

Pommier

2018

Clinics in Colon and Rectal Surgery

View full text Add to dashboard Cite

Neuroendocrine tumors, or carcinoid tumors, of both the midgut and hindgut are quite rare, but their incidence is increasing. Surgery is the treatment of choice in patients who can tolerate an operation and have operable disease. Options for the treatment of metastatic disease include cytoreductive surgery, somatostatin analogues, interferon α, local liver therapies (hepatic arterial embolization, ablation), chemotherapy, Peptide-Receptor Radionucleotide Radiotherapy, angiogenesis inhibitors, and mammalian target of rapamycin inhibitors.

show abstract

Section: Hindgutmentioning

confidence: 99%

Small Bowel and Colorectal Carcinoids

Byrne

Pommier

2018

Clinics in Colon and Rectal Surgery

View full text Add to dashboard Cite

show abstract

“…The concentration of serum acid phosphatase may be elevated in the case of neoplasms demonstrating expression of the prostate-specific fraction [8,17,18] …”

Section: Biochemical Diagnosticsmentioning

confidence: 99%

Nowotwory neuroendokrynne jelita grubego — zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)

Starzyńska¹,

Londzin-Olesik

Bałdys-Waligórska

et al. 2017

Endokrynologia Polska

View full text Add to dashboard Cite

“…5 1.1 | Pathology NEN of the large intestine are classified and staged according to the current WHO classification of digestive tumours, 2022 update and 2017 AJCC Cancer Staging system. 3,6,7 Below are summarised the major features (Tables 1 and 2) and the link to the ENETS proposal for synoptic reporting: 8 https://www.enets.org/standardised-reports.html?file=files/enets/ customer/media/Standardised%20reports/Standard%20Report% 20Pathology_ColoRectal%20NEN_V4.pdf&cid=2784.…”

Section: Introduction -General Backgroundmentioning

confidence: 99%

“…NEN of the large intestine are classified and staged according to the current WHO classification of digestive tumours, 2022 update and 2017 AJCC Cancer Staging system 3,6,7 . Below are summarised the major features (Tables 1 and 2) and the link to the ENETS proposal for synoptic reporting: 8 …”

Section: Introduction ‐ General Backgroundmentioning

confidence: 99%

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours

Rinke

Ambrosini

Dromain

et al. 2023

J Neuroendocrinology

View full text Add to dashboard Cite

This ENETS guidance paper, developed by a multidisciplinary working group, provides an update on the previous colorectal guidance paper in a different format. Guided by key clinical questions practical advice on the diagnosis and management of neuroendocrine tumours (NET) of the caecum, colon, and rectum is provided. Although covered in one guidance paper colorectal NET comprises a heterogeneous group of neoplasms. The most common rectal NET are often small G1 tumours that can be treated by adequate endoscopic resection techniques. Evidence from prospective clinical trials on the treatment of metastatic colorectal NET is limited and discussion of patients in experienced multidisciplinary tumour boards strongly recommended.Neuroendocrine carcinomas (NEC) and mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) are discussed in a separate guidance paper.

show abstract

Untitled

Cited by 5 publications

References 37 publications

Small Bowel and Colorectal Carcinoids

Small Bowel and Colorectal Carcinoids

Nowotwory neuroendokrynne jelita grubego — zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours

Contact Info

Product

Resources

About